| ADT | Androgen Deprivation Therapy |
| AUC | Area Under the Curve |
| BCR | Biochemical Recurrence |
| cDNA | Complementary DNA |
| CRPC | Castration-Resistant Prostate Cancer |
| DEGs | Differentially Expressed Genes |
| EGF | Epidermal Growth Factor |
| EGFR | Epidermal Growth Factor Receptor |
| FC | Fold Change |
| FDR | False Discovery Rate |
| GEO | Gene Expression Omnibus |
| GO | Gene Ontology |
| GSEA | Gene Set Enrichment Analysis |
| HRG | High-Risk Group |
| HVGs | Highly Variable Genes |
| IHC | Immunohistochemistry |
| ICGs | Immune Checkpoint Genes |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| LASSO | Least Absolute Shrinkage and Selection Operator |
| LLPS | Liquid–Liquid Phase Separation |
| LRG | Low-Risk Group |
| mCRPC | Metastatic Castration-Resistant Prostate Cancer |
| mTOR | Mechanistic Target of Rapamycin |
| PCA | Principal Component Analysis |
| PCa | Prostate Cancer |
| PH | Proportional Hazards |
| PPI | Protein–Protein Interaction |
| QC | Quality Control |
| ROC | Receiver Operating Characteristic |
| RT-qPCR | Reverse Transcription Quantitative Polymerase Chain Reaction |
| scRNA-seq | Single-Cell RNA Sequencing |
| SGs | Stress Granules |
| SG-RGs | Stress Granule-Related Genes |
| TCGA | The Cancer Genome Atlas |
| TCGA-PRAD | The Cancer Genome Atlas Prostate Adenocarcinoma |
| TMB | Tumor Mutational Burden |
| Tregs | Regulatory T Cells |
| UMAP | Uniform Manifold Approximation and Projection |